Page 111 - 《中国药房》2025年10期

toxicity induced by capecitabine and oxaliplatin in gastric com.cn/CN/10.3877/cma.j.issn.2095-3224.2019.02.004.
cancer treatment：a rare case of cardiac arrest and cardio‐ [26] GONG J Y，PENG S Y，XING K，et al. Evaluating the
genic shock[J]. Eur J Case Rep Intern Med，2024，11（4）： role of GSTP1 genetic polymorphism（rs1695，313A>G）
004417. as a predictor in cyclophosphamide-induced toxicities[J].
[15] SKINNER K T，PALKAR A M，HONG A L. Genetics of Medicine（Baltimore），2021，100（11）：e24423.
ABCB1 in cancer[J]. Cancers（Basel），2023，15（17）： [27] KIM W，CHO Y A，KIM D C，et al. Association between
4236. genetic polymorphism of GSTP1 and toxicities in patients
[16] GUDUR R A，BHOSALE S J，GUDUR A K，et al. Influ‐ receiving platinum-based chemotherapy：a systematic re‐
ence of（C1236T and C3435T）polymorphisms of ABCB1 view and meta-analysis[J]. Pharmaceuticals（Basel） ，
gene on chemotherapy treatment outcome and toxicity in 2022，15（4）：439.
breast cancer patients[J]. Asian Pac J Cancer Prev，2024， [28] SIMEUNOVIC D，ODANOVIC N，PLJESA-ERCEGOVAC
25（5）：1567-1577. M，et al. Glutathione transferase P1 polymorphism might
[17] SAQIB M，DIN Z S，ZAFAR S，et al. Lung cancer，plati‐ be a risk determinant in heart failure[J]. Dis Markers，
num analog-based frontline treatment and pharmacoge‐ 2019，2019：6984845.
netic limitations[J]. Per Med，2024，21（6）：385-400. [29] MUCO E，PATAIL H，SHAIK A，et al. Capecitabine-
[18] PUERTA-GARCÍA E，URBANO-PÉREZ D，CARRASCO- associated coronary vasospasm and cardiac arrest[J]. Cu‐
CAMPOS M I，et al. Effect of DPYD，MTHFR，ABCB1， reus，2022，14（8）：e28184.
XRCC1，ERCC1 and GSTP1 on chemotherapy related [30] KANDURI J，MORE L A，GODISHALA A，et al.
toxicity in colorectal carcinoma[J]. Surg Oncol，2020，35： Fluoropyrimidine-associated cardiotoxicity[J]. Cardiol Clin，
388-398. 2019，37（4）：399-405.
[19] CHEN S J，HUO X，LIN Y，et al. Association of MDR1 [31] DE TROIA B，DALU D，FILIPAZZI V，et al. ABCB1
and ERCC1 polymorphisms with response and toxicity to c.3435C>T polymorphism is associated with platinum toxi-
cisplatin-based chemotherapy in non-small-cell lung can‐ city：a preliminary study[J]. Cancer Chemother Pharma‐
cer patients[J]. Int J Hyg Environ Health，2010，213（2）： col，2019，83（4）：803-808.
140-145. [32] DU J W，SUDLOW L C，SHAHVERDI K，et al.
[20] XIE P，MO J L，LIU J H，et al. Pharmacogenomics of 5- Oxaliplatin-induced cardiotoxicity in mice is connected to
fluorouracil in colorectal cancer：review and update[J]. the changes in energy metabolism in the heart tissue[J].
Cell Oncol（Dordr），2020，43（6）：989-1001. bioRxiv，2023，24：542198.
[21] CURA Y，PÉREZ-RAMÍREZ C，SÁNCHEZ-MARTÍN [33] LYON A R，LÓPEZ-FERNÁNDEZ T，COUCH L S，et al.
A，et al. Influence of single-nucleotide polymorphisms on 2022 ESC Guidelines on cardio-oncology developed in
clinical outcomes of capecitabine-based chemotherapy in collaboration with the European Hematology Association
colorectal cancer patients：a systematic review[J]. Cancers （EHA），the European Society for Therapeutic Radiology
（Basel），2023，15（6）：1821. and Oncology（ESTRO）and the International Cardio-
[22] PIETRUSZYŃSKA-RESZETARSKA A，PIETRUSZYŃSKI Oncology Society（IC-OS）[J]. Eur Heart J，2022，43（41）：
R，IRZMAŃSKI R. The significance of genetically deter‐ 4229-4361.
mined methylation and folate metabolism disorders in the [34] RAJAEINEJAD M，PARHIZKAR-ROUDSARI P，KHOSHFETRAT
pathogenesis of coronary artery disease：a target for new M，et al. Management of fluoropyrimidine-induced car‐
therapies?[J]. Int J Mol Sci，2024，25（13）：6924. diac adverse outcomes following cancer treatment[J]. Car‐
[23] ETIENNE-GRIMALDI M C，PALLET N，BOIGE V，et diovasc Toxicol，2024，24（2）：184-198.
al. Current diagnostic and clinical issues of screening for [35] LADAK I，PRETI B，DIAS B，et al. Raltitrexed as a sub‐
dihydropyrimidine dehydrogenase deficiency[J]. Eur J stitute for capecitabine in metastatic gastric cancer：a case
Cancer，2023，181：3-17. report and literature review[J]. Ann Transl Med，2022，10
[24] ATASILP C，VANWONG N，YODWONGJANE P，et al. （23）：1285.
Influence of DPYD gene polymorphisms on 5-fluorouracil [36] KINOS S，HAGMAN H，HALONEN P，et al. Detailed
toxicities in Thai colorectal cancer patients[J]. Cancer analysis of metastatic colorectal cancer patients who de‐
Chemother Pharmacol，2024，95（1）：2-13. veloped cardiotoxicity on another fluoropyrimidine and
[25] 苟苗苗，张勇，千年松，等 . DPYD、ABCB1、GSTP1、 switched to S-1 treatment（subgroup analysis of the
ERCC1基因多态性与晚期结肠癌临床特征、不良反应、 CardioSwitch-study）[J]. Acta Oncol，2024，63：248-258.
预后的关系[J/OL]. 中华结直肠疾病电子杂志，2019，8 （收稿日期：2025-01-14 修回日期：2025-04-15）
（2）：125-130[2025-01-13]. https：//zhjzcjbdzzz. cma-cmc. （编辑：舒安琴）

中国药房 2025年第36卷第10期 China Pharmacy 2025 Vol. 36 No. 10 · 1253 ·